GSK-EZH117208

Study Sponsor: GSK

Study Title

A phase I open-label, dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK2816126 in subjects with relapsed/refractory diffuse large B cell lymphoma, transformed follicular lymphoma, other Non-Hodgkin’s lymphomas, solid tumors and multiple myeloma

Medicine or Vaccine (generic name)

GSK2816126

Sponsor Identification Number

EZH117208

Trial Registry Identification Number(#'s)

NCT02082977 2013-001585-42

Medical Condition

Neoplasms

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=117208

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02082977

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2013-001585-42

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

October 2019